- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-14
DOI
10.3389/fonc.2020.00600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
- (2019) Troy E. Messick et al. Science Translational Medicine
- Novel cationic Bis(acylhydrazones) as modulators of Epstein–Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA
- (2019) Oksana Reznichenko et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication
- (2019) Kimberly A. Malecka et al. JOURNAL OF VIROLOGY
- Development of Allosteric BRAF Peptide Inhibitors Targeting the Dimer Interface of BRAF
- (2019) Amber Y. Gunderwala et al. ACS Chemical Biology
- Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression Without Virion Production
- (2019) Jaeyeun Lee et al. JOURNAL OF VIROLOGY
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
- (2019) Miao Xu et al. NATURE GENETICS
- Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway
- (2019) An-Ko Chung et al. Cancer Medicine
- Translational genomics of nasopharyngeal cancer
- (2019) Chi Man Tsang et al. SEMINARS IN CANCER BIOLOGY
- Control of Viral Latency by Episome Maintenance Proteins
- (2019) Alessandra De Leo et al. TRENDS IN MICROBIOLOGY
- Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma
- (2019) Stephanie Pei Tung Yiu et al. Cancers
- Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
- (2019) Rob J. A. Verhoeven et al. Frontiers in Oncology
- Reactivation of Epstein–Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function
- (2019) Lijun Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma
- (2018) Raymond W-M Lung et al. JOURNAL OF PATHOLOGY
- Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
- (2018) K.H. Au et al. ORAL ONCOLOGY
- EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
- (2018) Joanna Wilson et al. Cancers
- The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis
- (2018) Abigail Morales-Sánchez et al. Cancers
- Responsive upconversion nanoprobe for monitoring and inhibition of EBV-associated cancers via targeting EBNA1
- (2018) Shuai Zha et al. Nanoscale
- High risk Epstein‐Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma
- (2018) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers
- (2018) Stephanie Yiu et al. Cancers
- Investigational drugs for nasopharyngeal carcinoma
- (2017) Brigette B.Y. Ma et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma
- (2017) Jiangxue Wu et al. HUMAN GENE THERAPY
- Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model
- (2017) Zlata Novalić et al. JOURNAL OF MEDICAL VIROLOGY
- Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance
- (2017) Julianna S. Deakyne et al. JOURNAL OF VIROLOGY
- Epstein–Barr virus infection and nasopharyngeal carcinoma
- (2017) Sai Wah Tsao et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
- (2017) Yvonne Y Li et al. Nature Communications
- Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA
- (2017) María José Lista et al. Nature Communications
- Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
- (2017) Jayaraju Dheekollu et al. Oncotarget
- Theranostic DNAzymes
- (2017) Wenhu Zhou et al. Theranostics
- EBNA1-targeted probe for the imaging and growth inhibition of tumours associated with the Epstein–Barr virus
- (2017) Lijun Jiang et al. Nature Biomedical Engineering
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease
- (2016) Jonathan E. Gable et al. ChemMedChem
- Elucidating the druggable interface of protein−protein interactions using fragment docking and coevolutionary analysis
- (2016) Fang Bai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
- (2015) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma
- (2015) Sharon D. Stoker et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
- (2015) Anne W.M. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by InhibitingBAD-Mediatedcaspase-3-Dependent Apoptosis
- (2015) Hyoji Kim et al. JOURNAL OF VIROLOGY
- Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region
- (2015) Aron R. Marquitz et al. JOURNAL OF VIROLOGY
- 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch
- (2015) Coral K. Wille et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells
- (2015) Adityarup Chakravorty et al. VIROLOGY
- EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
- (2015) Zhi Li et al. Oncotarget
- Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation
- (2015) Hyun Gyu Lee et al. Oncotarget
- Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
- (2015) Cheng-Lung Hsu et al. Oncotarget
- Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies
- (2015) Chung King Choi et al. PLoS One
- EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells
- (2014) Lijun Jiang et al. CHEMICAL COMMUNICATIONS
- The role of Epstein-Barr virus in epithelial malignancies
- (2014) Sai-Wah Tsao et al. JOURNAL OF PATHOLOGY
- Epstein-Barr Virus EBNA1 Protein Regulates Viral Latency through Effects on let-7 MicroRNA and Dicer
- (2014) S. Mansouri et al. JOURNAL OF VIROLOGY
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Etiological factors of nasopharyngeal carcinoma
- (2014) Sai Wah Tsao et al. ORAL ONCOLOGY
- Regulation of the latent-lytic switch in Epstein–Barr virus
- (2014) Shannon C. Kenney et al. SEMINARS IN CANCER BIOLOGY
- Modelling the structure of full-length Epstein–Barr virus nuclear antigen 1
- (2014) Mushtaq Hussain et al. VIRUS GENES
- Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells
- (2013) Y.-R. Liu et al. JOURNAL OF GENERAL VIROLOGY
- Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells
- (2013) Rebecca J Port et al. JOURNAL OF PATHOLOGY
- Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus
- (2013) K. F. Hui et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic Evaluation of Epstein-Barr Virus-encoded Latent Membrane Protein-1 Targeted DNAzyme for Treating of Nasopharyngeal Carcinomas
- (2013) Ya Cao et al. MOLECULAR THERAPY
- Reactive Oxygen Species Mediate Epstein-Barr Virus Reactivation by N-Methyl-N’-Nitro-N-Nitrosoguanidine
- (2013) Sheng-Yen Huang et al. PLoS One
- BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator
- (2013) Eveline K. Hoebe et al. REVIEWS IN MEDICAL VIROLOGY
- Human Leukocyte Antigens and Epstein–Barr Virus-Associated Nasopharyngeal Carcinoma: Old Associations Offer New Clues into the Role of Immunity in Infection-Associated Cancers
- (2013) Wen-Hui Su et al. Frontiers in Oncology
- Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization
- (2012) Sun Young Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cytolytic Virus Activation Therapy for Epstein-Barr Virus-Driven Tumors
- (2012) M. A. Wildeman et al. CLINICAL CANCER RESEARCH
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- The pathological roles of BART miRNAs in nasopharyngeal carcinoma
- (2012) Angela K-F Lo et al. JOURNAL OF PATHOLOGY
- Functions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection
- (2012) N. Sivachandran et al. JOURNAL OF VIROLOGY
- Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication
- (2012) C. K. Wille et al. JOURNAL OF VIROLOGY
- Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
- (2012) C. M. Tsang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
- (2012) Christopher W. Dawson et al. SEMINARS IN CANCER BIOLOGY
- Epstein-Barr Virus Latent Membrane Protein 1 Induces Cancer Stem/Progenitor-Like Cells in Nasopharyngeal Epithelial Cell Lines
- (2011) S. Kondo et al. JOURNAL OF VIROLOGY
- Valproic Acid Antagonizes the Capacity of Other Histone Deacetylase Inhibitors To Activate the Epstein-Barr Virus Lytic Cycle
- (2011) D. Daigle et al. JOURNAL OF VIROLOGY
- Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma
- (2011) Yufang Zuo et al. PLoS One
- N-methyl-N′-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells
- (2010) Sheng-Yen Huang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Interplay between PKC and Sp1 on Histone Deacetylase Inhibitor-Mediated Epstein-Barr Virus Reactivation
- (2010) P.-F. Tsai et al. JOURNAL OF VIROLOGY
- EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model
- (2010) Xia Ke et al. MEDICAL ONCOLOGY
- Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening
- (2010) Ning Li et al. PLoS One
- Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation
- (2010) Sebastien Apcher et al. PLoS Pathogens
- Molecular Mechanisms of Mouse Skin Tumor Promotion
- (2010) Joyce E. Rundhaug et al. Cancers
- Transcription of the Epstein–Barr Virus Lytic Cycle Activator BZLF-1 During Oxidative Stress Induction
- (2009) Saloua Lassoued et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death
- (2009) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Optimal Transactivation by Epstein-Barr Nuclear Antigen 1 Requires the UR1 and ATH1 Domains
- (2009) G. Singh et al. JOURNAL OF VIROLOGY
- Role for G-Quadruplex RNA Binding by Epstein-Barr Virus Nuclear Antigen 1 in DNA Replication and Metaphase Chromosome Attachment
- (2009) J. Norseen et al. JOURNAL OF VIROLOGY
- Zinc Coordination Is Required for and Regulates Transcription Activation by Epstein-Barr Nuclear Antigen 1
- (2009) Siddhesh Aras et al. PLoS Pathogens
- RNA-dependent recruitment of the origin recognition complex
- (2008) Julie Norseen et al. EMBO JOURNAL
- Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells
- (2008) Chih-Yeu Fang et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containingoriP
- (2008) Leyao Wang et al. JOURNAL OF GENE MEDICINE
- Essential role of PKC in histone deacetylase inhibitor-induced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells
- (2008) H.-H. Lee et al. JOURNAL OF GENERAL VIROLOGY
- mRNA Translation Regulation by the Gly-Ala Repeat of Epstein-Barr Virus Nuclear Antigen 1
- (2008) S. Apcher et al. JOURNAL OF VIROLOGY
- Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
- (2008) M Samanta et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started